ImmunoGen Inc.

Available to platforms

ImmunoGen Inc. (Ticker: IMGN) is a biotechnology company focused on developing antibody-drug conjugates (ADCs) for the treatment of cancer. ADCs are targeted therapies that combine monoclonal antibodies with potent anti-cancer agents, allowing for precise delivery of the treatment to cancer cells while minimizing impact on healthy tissue. ImmunoGen’s lead product, Elahere (mirvetuximab soravtansine), is approved for the treatment of certain ovarian cancers. The company continues to advance its pipeline of ADC candidates to address unmet medical needs in oncology.

ImmunoGen Inc. - IMGN stocks live chart

Analyze price movements of ImmunoGen Inc. online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous IMGN quotes – including the latest bid at 31.23 USD and ask at 31.25 USD – and get all the necessary information for adding ImmunoGen Inc. to your investment portfolio.

With R StocksTrader, you can invest in ImmunoGen Inc. and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like ImmunoGen Inc., and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of IMGN does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for ImmunoGen Inc. (IMGN).

You can trade ImmunoGen Inc. (IMGN) on the R StocksTrader platform.

You can trade online ImmunoGen Inc. (IMGN) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts